Work

Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)

Year: 2015

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v126.23.1987.1987

Authors: Brian T. Hill, Lisa A. Rybicki, Catherine Weber, Deepa Jagadeesh, Aaron T. Gerds, Betty K. Hamilton, Hien K. Liu, Robert M. Dean, Ronald M. Sobecks, Brad Pohlman, Steven Andresen, Matt Kalaycio, Brian J. Bolwell, Navneet S. Majhail

Institutions: Cleveland Clinic, Cleveland Clinic Research

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2528658183

FWCI:

Cites:

Cited by:

Related to: 10